Hub Group is undervalued with a positive future outlook not yet reflected in its share price, suggesting it's a good time to buy HUBG. Consideration of management track record and capital structure is also advised.
Hub Group's returns on capital remain steady, despite increased capital employed, indicating a lack of high return investments. If current trends persist, its chances of becoming a multi-bagger are slim.
Hub Group's robust EPS growth in recent years doesn't change the prediction that its future earnings growth may underperform market average. This is likely contributing to its P/E ratio staying below market levels. Without major improvements, its stock isn't forecasted to notably increase soon.
Hub Group's strong financials and profit utilization spell a positive outlook despite recent stock performance. Its hearty growth rate and reinvestment strategy could boost value, though future earnings growth may slow down.
Gainers: •$クロビス・オンコロジー(CLVS.US)$+40.6% (Rubraca significantly improves progression-free survival in first-line maintenance treatment in women with ovarian cancer regardless of their biomarker status in phase 3 athena-mono trial) •$デア バイオサイエンス(DARE.US)$+13.61% (Organon and Dar Bioscience have entered into an agreement whereby Organon will license global rights to XACIATO) •$KULR テクノロジー グループ(KULR.US)$+9.5% (secured a battery sa...
ハブ グループ Aに関するコメント
• $アメリカン エキスプレス(AXP.US)$ : Baird Upgrades to Outperform from Neutral - PT $175
• $AZEK Co Inc/The(AZEK.US)$ : BofA Securities Upgrades to Buy from Neutral
• $キャピタル ワン ファイナンシャル(COF.US)$ : Baird Upgrades to Outperform from Neutral - PT $145
• $フィフス サード バンコープ(FITB.US)$ : Baird Upgrades to Outperform from Neutral - PT $44
• $M&T バンク(MTB.US)$ : Baird Upgrades to Outperform from Neutral - PT $200 (from $175)
• $ネクストエラ エナジー パートナーズ(NEP.US)$ : RBC Cap...
• $GTY Technology(GTYH.US)$ +118.1% (entered into a definitive agreement to be acquired by GI Partners )
• $フィンチ セラピューティクス(FNCH.US)$ +68.33% (announces removal of FDA clinical hold on CP101 IND)
• $ジムワークス(ZYME.US)$ +42.34% (confirms receipt of non-binding proposal from All Blue Falcons for $10.50 per share in cash)
• $ハブ グループ A(HUBG.US)$ +16.3% (earnings reports)
• $ランセウス ホールディングス(LNTH.US)$ +14.2% (earnings reports)
• $モホーク インダストリーズ(MHK.US)$ +13.7% (e...
• $Fortune Brands Home & Security(FBHS.US)$ : BofA Securities Upgrades to Neutral from Underperform - PT $84 (from $74)
• $フォワード エアー コーポレーション(FWRD.US)$ : Stifel Upgrades to Buy from Hold - PT $136 (from $122)
• $グローサリー アウトレット ホールディングス(GO.US)$ : BofA Securities Upgrades to Buy from Underperform - PT $37 (from $23)
• $ハブ グループ A(HUBG.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $92 (from $76)
• $アイキューヴァイア ホールディングス(IQV.US)$ : Piper Sandler Upgrades to Overweight...
• $ベーカーヒューズ A(BKR.US)$ : HSBC Upgrades to Buy from Hold - PT $38.30
• $コンパニア・セルベセリアス・ウニダス(CCU.US)$ : HSBC Upgrades to Buy from Hold - PT $17
• $キャピタル シティー バンク グループ(CCBG.US)$ : Piper Sandler Upgrades to Overweight from Neutral - PT $31.50 (from $29)
• $ハブ グループ A(HUBG.US)$ : Susquehanna Upgrades to Positive from Neutral - PT $83 (from $92)
• $インタラクティブ ブローカーズ グループ A(IBKR.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $90
• $JB ハント トランスポート サービシズ(JBHT.US)$ : Susqueh...
• $クロビス・オンコロジー(CLVS.US)$ +40.6% (Rubraca significantly improves progression-free survival in first-line maintenance treatment in women with ovarian cancer regardless of their biomarker status in phase 3 athena-mono trial)
• $デア バイオサイエンス(DARE.US)$ +13.61% (Organon and Dar Bioscience have entered into an agreement whereby Organon will license global rights to XACIATO)
• $KULR テクノロジー グループ(KULR.US)$ +9.5% (secured a battery sa...
• $ベーカーヒューズ A(BKR.US)$ : Wells Fargo Upgrades to Overweight from EqualWeight - PT $43
• $CDW(CDW.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $214 (from $201)
• $コアメイン A(CNM.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $34 (from $32)
• $ファイブ ビロウ(FIVE.US)$ : Citigroup Upgrades to Buy from Neutral - PT $205 (from $176)
• $ベクター グループ(VGR.US)$ : Barclays Uprages to Overweight from Equal Weight - PT $16 (from ...
まだコメントはありません